SCHEMBL4158747

SCHEMBL4158747

Cc1ccc2nc(Nc3ccc(Oc4ccncc4)cc3)[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.59
CSNK1A1 P48729 6/20 0.59
CSNK1D P48730 6/20 0.59
GSK3B P49841 5/20 0.56
CSNK1G2 P78368 5/20 0.56
ADORA2A P29274 1/20 0.53
RAF1 P04049 6/20 0.53
BRAF P15056 5/20 0.51
PDE10A Q9Y233 3/20 0.50
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164550 0.87 CSNK1A1 (0.59) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL4164763 0.86 KDR (0.54) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL4161824 0.85 CSNK1D (0.80) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL13906245 0.85 KDR (0.59) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL4170820 0.82 KDR (0.59) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL4164511 0.82 KDR (0.67) KDRCSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL13906249 0.82 PDE10A (0.70) KDRCSNK1A1CSNK1DPDE10ARAB9A
SCHEMBL4173612 0.82 RAF1 (0.55) KDRCSNK1A1CSNK1DRAF1BRAF
SCHEMBL5733440 0.82 KDR (0.56) KDRCSNK1A1CSNK1DRAF1BRAF
SCHEMBL5733146 0.81 KDR (0.58) KDRCSNK1A1CSNK1DGSK3BCSNK1G2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082404-A1 BENZIMIDAZOLES MERCK PATENT GMBH (DE) 2009-03-26 US claimed
US-7470702-B2 Benzimidazoles MERCK PATENT GMBH (DE) 2008-12-30 US claimed
US-20070066660-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-03-22 US claimed
EP-1675849-A1 BENZIMIDAZOLYL DERIVATIVES MERCK PATENT GmbH (DE) 2006-07-05 EP claimed
WO-2005042520-A1 BENZIMIDAZOLYL DERIVATIVES MERCK PATENT GMBH (DE) 2005-05-12 WO claimed
US-20090082404-A1 BENZIMIDAZOLES MERCK PATENT GMBH (DE) 2009-03-26 US disclosed
US-20090082404-A1 BENZIMIDAZOLES MERCK PATENT GMBH (DE) 2009-03-26 US disclosed
US-20090082404-A1 BENZIMIDAZOLES MERCK PATENT GMBH (DE) 2009-03-26 US disclosed
US-7470702-B2 Benzimidazoles MERCK PATENT GMBH (DE) 2008-12-30 US disclosed
US-7470702-B2 Benzimidazoles MERCK PATENT GMBH (DE) 2008-12-30 US disclosed
US-7470702-B2 Benzimidazoles MERCK PATENT GMBH (DE) 2008-12-30 US disclosed
US-20070066660-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066660-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066660-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
EP-1675849-A1 BENZIMIDAZOLYL DERIVATIVES MERCK PATENT GmbH (DE) 2006-07-05 EP disclosed
WO-2005042520-A1 BENZIMIDAZOLYL DERIVATIVES MERCK PATENT GMBH (DE) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082404-A1 BENZIMIDAZOLES TIE1, KDR, FLT1 KDR 2/4885CSNK1A1 2182/4885CSNK1D 1595/4885
US-20070066660-A1 Benzimidazolyl derivatives TIE1, ECE2, ABL1 KDR 5/4885CSNK1A1 2047/4885CSNK1D 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.